Use of IL-17 inhibitors is effective and safe for the treatment of PsO involving difficult-to-treat anatomical sites.

Patients with inflammatory/autoimmune diseases who initiated treatment with interleukin (IL)-17 inhibitors did not have a higher risk for the development of ...

A new study has found that biologic class and treatment sequencing influences psoriatic arthritis risk in patients with ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Although TNF inhibitors remain the first choice biologic ...

DiCE Molecules is setting its sights on the clinic. With $80 million raised from a laundry list of investors led by RA Capital Management, the company will push its lead program, an interleukin-17 (IL ...